Medicine & Life Sciences

1. Lopinavir 100%
2. Hydroxychloroquine 87%
3. Coronavirus 76%
4. riociguat 76%
5. GS-5734 55%
6. Ritonavir 55%
7. Pulmonary Hypertension 43%
8. Age of Onset 41%
9. Registries 38%
10. Antiviral Agents 37%
11. Parkinson Disease 36%
12. Safety 30%
13. Randomized Controlled Trials 29%
14. Phenotype 26%
15. Interferons 24%
16. Confidence Intervals 20%
17. Severe Acute Respiratory Syndrome 16%
18. Ventilation 14%
19. Mortality 13%
20. Drug and Narcotic Control 12%
21. Pharmaceutical Preparations 11%
22. Investigational Therapies 10%
23. Random Allocation 10%
24. Medical Dictionaries 10%
25. Edema 10%
26. Pneumonia 10%
27. Standard of Care 9%
28. Heart Failure 9%
29. Odds Ratio 8%
30. Interferon beta-1a 8%
31. Therapeutics 8%
32. Soluble Guanylyl Cyclase 7%
33. Inpatients 7%
34. Hemoptysis 7%
35. Pulmonary Arterial Hypertension 7%
36. Syncope 6%
37. Dizziness 6%
38. Intention to Treat Analysis 6%
39. Ambulatory Care 6%
40. Hypotension 5%
41. Dyspnea 5%
42. Hospital Mortality 5%
43. Artificial Respiration 5%